DK0537168T3 - Antigenet CTAA 28A32, som genkendes af MCA 28A32 - Google Patents

Antigenet CTAA 28A32, som genkendes af MCA 28A32

Info

Publication number
DK0537168T3
DK0537168T3 DK91909273.4T DK91909273T DK0537168T3 DK 0537168 T3 DK0537168 T3 DK 0537168T3 DK 91909273 T DK91909273 T DK 91909273T DK 0537168 T3 DK0537168 T3 DK 0537168T3
Authority
DK
Denmark
Prior art keywords
epitope
antigen
mca
recognized
human
Prior art date
Application number
DK91909273.4T
Other languages
Danish (da)
English (en)
Inventor
Nicholas Pomato
Ebo Sybren Bos
Janet Hazel Ransom
Michael George Hanna
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Application granted granted Critical
Publication of DK0537168T3 publication Critical patent/DK0537168T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3046—Stomach, Intestines
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57446—Specifically defined cancers of stomach or intestine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Seeds, Soups, And Other Foods (AREA)
DK91909273.4T 1990-04-12 1991-04-10 Antigenet CTAA 28A32, som genkendes af MCA 28A32 DK0537168T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US50837390A 1990-04-12 1990-04-12

Publications (1)

Publication Number Publication Date
DK0537168T3 true DK0537168T3 (da) 1996-09-02

Family

ID=24022500

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91909273.4T DK0537168T3 (da) 1990-04-12 1991-04-10 Antigenet CTAA 28A32, som genkendes af MCA 28A32

Country Status (12)

Country Link
EP (1) EP0537168B1 (de)
JP (1) JPH05507470A (de)
KR (1) KR100206061B1 (de)
AT (1) ATE138200T1 (de)
AU (1) AU660927B2 (de)
CA (1) CA2079601A1 (de)
DE (1) DE69119591T2 (de)
DK (1) DK0537168T3 (de)
ES (1) ES2090331T3 (de)
FI (1) FI924576A0 (de)
GR (1) GR3020387T3 (de)
WO (1) WO1991016629A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5705401A (en) * 1991-11-12 1998-01-06 The University Of Melbourne Method of assaying for alzheimer's disease
US6969518B2 (en) 1998-12-28 2005-11-29 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US7598226B2 (en) 1998-12-28 2009-10-06 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US6387697B1 (en) 1998-12-28 2002-05-14 Corixa Corporation Compositions for treatment and diagnosis of breast cancer and methods for their use
CA2392510A1 (en) 1999-11-30 2001-06-07 Corixa Corporation Compositions and methods for therapy and diagnosis of breast cancer
WO2001073027A2 (en) * 2000-03-24 2001-10-04 Corixa Corporation Compositions and methods for therapy and diagnosis of colon cancer

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ210867A (en) * 1984-01-31 1989-01-06 Litton Bionetics Inc Tumour-specific monoclonal antibodies, production thereof and use
NO861491L (no) * 1985-04-22 1986-10-23 Hybritech Inc Antistoff, fremgangsmaate for dets fremstilling og anvendelse for deteksjon og diagnose av canser.
WO1989000050A1 (en) * 1987-07-02 1989-01-12 Akzo N.V. Antigen recognized by mca 16-88

Also Published As

Publication number Publication date
FI924576A (fi) 1992-10-09
ATE138200T1 (de) 1996-06-15
EP0537168A1 (de) 1993-04-21
AU660927B2 (en) 1995-07-13
CA2079601A1 (en) 1991-10-13
DE69119591T2 (de) 1996-09-12
JPH05507470A (ja) 1993-10-28
EP0537168A4 (en) 1993-05-05
EP0537168B1 (de) 1996-05-15
ES2090331T3 (es) 1996-10-16
AU7788491A (en) 1991-11-11
GR3020387T3 (en) 1996-09-30
FI924576A0 (fi) 1992-10-09
KR100206061B1 (ko) 1999-07-01
DE69119591D1 (de) 1996-06-20
WO1991016629A1 (en) 1991-10-31

Similar Documents

Publication Publication Date Title
ATE301471T1 (de) Verwendung von antikörpen gegen cd45ro leukozytenantigen zur immunmodulation
DE69230545D1 (de) Antikörperderivate
NO994983D0 (no) Fremgangsmåte for fremstilling av anti-humane antigenreseptorer, samt anvendelse av disse
DK40885A (da) Monoklonalt antistof, fremgangsmaade og celle til fremstilling deraf,fremgangsmaade til fremstilling af cellen og farmaceutisk praeparat indeholdende det monoklonale antistof
FI900230A0 (fi) Anti-idiotypa antikroppar mot antikroppar mot antigener med hoeg molekylvikt associerade till human melanoma.
DK424988D0 (da) Specifikke ekskretion -sekretion-antigener af toxoplasma gondii, ekspressionsprodukter deraf, fremgangsmaade til fremstilling deraf og diagnostiske og profylaktiske anvendelser deraf
DK0537168T3 (da) Antigenet CTAA 28A32, som genkendes af MCA 28A32
DE69327529D1 (de) Immunologisch mit HLA homologe HIV Protein Epitope
DK102589A (da) Antigen, der genkendes af mca 16-88
ATE77243T1 (de) E87ag-antigen des pseudomonas aeruginosa, monoklonale antikoerper dagegen und hybridom.
NO922941D0 (no) Medikamenter og fremgangsmaater for behandling av aids og aids-relatert kompleks ved anvendelse av anti-karbohydrat-antistoffer og karbohydrat-antigener
NO924803L (no) Tumor-relatert monoklonalt antistoff 88bv59
SE8401946D0 (sv) Antibody to human prostate cancer
DE3777196D1 (de) Anti-parathyroid-antikoerper-praeparat.
Percy The immune response to Schistosoma mansoni: Studies on anti-idiotypic regulation and identification of molecules with potential for vaccine development.
ATE95426T1 (de) Humanes karcinom-assoziertes antigen und an dieses antigen bindende antikoerper.
DK182188A (da) Humant tumorassocieret antigen
BG50103A1 (en) Hybridome cell line, secretting monoclonal antibody against antigene determinante noc- 2 of malignant melanom in human